Ellington Management Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-829
| Closed | -$131K | – | 615 |
|
|
2015
Q3 | $131K | Buy |
+829
| New | +$131K | 0.04% | 636 |
|
|
2015
Q1 | – | Sell |
-787
| Closed | -$215K | – | 698 |
|
|
2014
Q4 | $215K | Buy |
+787
| New | +$215K | 0.07% | 430 |
|
|
2014
Q2 | – | Sell |
-687
| Closed | -$182K | – | 474 |
|
|
2014
Q1 | $182K | Buy |
+687
| New | +$182K | 0.05% | 542 |
|
|
2013
Q3 | – | Sell |
-1,593
| Closed | -$373K | – | 783 |
|
|
2013
Q2 | $373K | Buy |
+1,593
| New | +$373K | 0.07% | 425 |
|